EA
Euroapi S.A.
EAPIF · OTC
$1.17 +0.00% (+$0.00)
Market Cap 96.8M €
P/E Ratio -
Div. Yield -
ROE 26.46%
Bulios Fair Price
$0.97
17.1% downside
Current Price
$1.17
Undervalued Fair Value Overvalued
According to Bulios Fair Price, EAPIF is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Moderate
4/9Valuation
100 /100
Cheap EV/EBITDA 0.34x
P/S 0.11x
P/B 0.12x
Growth
0 /100
Declining Rev. growth 4.74%
Book val. growth 10.81%
EPS growth N/A
Profitability
17 /100
Weak Gross margin 16.56%
Net margin 24.90%
Op. margin 0.21%
Quality
8 /100
Poor ROIC 0.26%
ROE 26.46%
ROA 16.19%
Debt
80 /100
Low Debt/Equity 0.08x
Current ratio 2.60x
Int. coverage 0.15x
Stability
53 /100
Moderate Beta 0.98x
Rev. volatility 7.37%
EPS volatility 660.47%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about EAPIF
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
David Seignolle
Employees
3,133
Headquarters
Paris
Upcoming events
09 MAR
Earnings
Upcoming earnings report